Skip to main content
OpenTrials
Completed

NCT Number: NCT02494401

Taking Charge of Systemic Sclerosis

This Study is a collaborative project with partners (people with scleroderma and stakeholders) designed to refine an internet program for patients with scleroderma and to compare the internet program to an authoritative educational book (Taking Charge of Systemic Sclerosis [TOSS]). During a 16-week comparative effectiveness 16-week randomized controlled trial, the investigators will recruit up to 250 patients who will be randomized to either TOSS or authoritative book for patients, The Scleroderma Book: A Guide for Patients and Families.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All participants will be residents of the United States
  • Diagnosed with systemic scleroderma,
  • 18 years of age
  • Possess basic computer literacy and have access to a computer with Internet and email capabilities
  • Have the ability to communicate in English

Exclusion criteria

  • No computer access
  • Inability to communicate in English

Treatment and study plan

Internet-based self-management program

Other

Scleroderma book

Other

Primary outcomes

  1. Change in Managing Symptoms Scale on the PROMIS® Self-efficacy Short Form 8

    Time frame: Baseline compared with 16 weeks, 6 months

    Managing Symptoms score on the PROMIS® Self-efficacy Short Form 8 consists of 8 items scored from 1 (not at all confident) to 5 (very confident), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. Higher scores are indicative of greater ability to manage symptoms.

Secondary outcomes

  1. Change in Quality of Life on the European Quality of Life-5 Dimensions (EQ-5D) Index Scale

    Time frame: Baseline compared with 16 weeks, 6 months

    EQ-5D index scale uses a conversion algorithm to convert the raw scores into a health utility measure, ranging from 0.0 (death) to 1.0 (full or optimal health).

  2. Change in Confidence in Self Management on the Patient Activation Measure Scale

    Time frame: Baseline compared with 16 weeks, 6 months

    The Patient Activation Measure (PAM) is a 13-item measure that assesses patient knowledge, skill, and confidence for self-management. Each item is scored from 1 (strongly disagree) to 4 (strongly agree). PAM scores were categorized into 4 levels: level 1, the individual is disengaged/overwhelmed; level 2, the individual is aware but struggling; level 3, the individual is taking action;and level 4, the individual is maintaining behavior. The analysis will look at any change in these levels where level 4 denotes someone as full "activated".

  3. Change in Brief Satisfaction on the Satisfaction With Appearance Scale (SWAP) Scale

    Time frame: Baseline compared with 16 weeks, 6 months

    The Brief Satisfaction with Appearance Scale (SWAP) is a 6-item scale measuring body image concerns and social discomfort with body parts. It is scored from 0 to 36, with higher scores associated with greater dissatisfaction.

  4. Change in Managing Daily Activities Scale on the PROMIS® Self-efficacy Short Form 8

    Time frame: Baseline compared to 16 weeks and 6 months

    Managing Daily Activities score on the PROMIS® Self-efficacy Short Form 8 consists of 8 items scored from 1 (not at all confident) to 5 (very confident), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. Higher scores are indicative of greater ability to manage symptoms.

  5. Change in Managing Emotions Scale on the PROMIS® Self-efficacy Short Form 8

    Time frame: Baseline compared to 16 weeks and 6 months

    Managing Emotions score on the PROMIS® Self-efficacy Short Form 8 consists of 8 items scored from 1 (not at all confident) to 5 (very confident), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. Higher scores are indicative of greater ability to manage symptoms.

  6. Change in Managing Medications and Treatment Scale on the PROMIS® Self-efficacy Short Form 8

    Time frame: Baseline compared to 16 weeks and 6 months

    Managing Medication and Treatment score on the PROMIS® Self-efficacy Short Form 8 consists of 8 items scored from 1 (not at all confident) to 5 (very confident), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. Higher scores are indicative of greater ability to manage symptoms.

  7. Change in Managing Social Interactions Scale on the PROMIS® Self-efficacy Short Form 8

    Time frame: Baseline compared to 16 weeks and 6 months

    Managing Social Interactions score on the PROMIS® Self-efficacy Short Form 8 consists of 8 items scored from 1 (not at all confident) to 5 (very confident), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. Higher scores are indicative of greater ability to manage symptoms.

  8. Change in Physical Function Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Physical Function domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents better physical function, a lower score represents poorer physical function.

  9. Change in Social Role Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Social role domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents better social role functioning and a lower score represents poorer social role functioning.

  10. Change in Anxiety Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Anxiety domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents worse symptomatology, a lower score represents better symptomatology.

  11. Change in Depression Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Depression domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents worse symptomatology, a lower score represents better symptomatology.

  12. Change in Fatigue Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Fatigue domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents worse symptomatology, a lower score represents better symptomatology.

  13. Change Pain Interference Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Pain interference domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much), this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents worse symptomatology, a lower score represents better symptomatology.

  14. Change in Visual Analogue Scale Pain Intensity Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    The visual analogue scale pain intensity in the PROMIS-29 Profile v2.0® is scored as 0 being no pain and 10 being the worst imaginable pain.

  15. Change in Sleep Disturbance Scale on the PROMIS® 29 Profile v 2.0 Outcome Measure

    Time frame: Baseline compared to 16 weeks and 6 months

    Sleep disturbance domain in the PROMIS-29 Profile v2.0® are scored from 1 (unable to do/never/not at all) to 5 (without any difficulty/always/very much),this provides a raw score. The raw score is translated to a T-Score using a conversion table supplied by the Assessment Center. A score of 50 is the average for the US general population with a standard deviation of 10. A higher score represents worse symptomatology, a lower score represents better symptomatology.

Other outcomes

  1. Change in PHQ-8

    Time frame: Baseline compared to 16 weeks and 6 months

    The Patient Health Questionnaire-8 (PHQ-8) is an 8-item questionnaire that is commonly used to measure depressive symptoms. A score of ≥10 is consistent with depressed mood with a score ranging from 0 to 24.

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Medical University of South Carolina
  • Patient-Centered Outcomes Research Institute
  • University of New Mexico

Registry information

Official study title

Taking Charge of Systemic Sclerosis: Improving Patient Outcomes Through Self-management

Acronym: TOSS

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Jul 10, 2015
Registry last updated
Aug 28, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.